Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
VNRX VolitionRx Limited daily Stock Chart
VNRX [AMEX]
VolitionRx Limited
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-0.44 Insider Own2.70% Shs Outstand41.20M Perf Week-8.76%
Market Cap165.00M Forward P/E- EPS next Y-0.49 Insider Trans0.00% Shs Float27.64M Perf Month18.30%
Income-17.70M PEG- EPS next Q-0.12 Inst Own7.50% Short Float1.97% Perf Quarter16.10%
Sales0.02M P/S9353.74 EPS this Y28.40% Inst Trans5.60% Short Ratio1.53 Perf Half Y-19.70%
Book/sh0.22 P/B17.05 EPS next Y-2.10% ROA-83.70% Target Price- Perf Year22.15%
Cash/sh0.27 P/C13.75 EPS next 5Y- ROE-123.30% 52W Range2.22 - 6.84 Perf YTD-20.89%
Dividend- P/FCF- EPS past 5Y7.60% ROI- 52W High-45.18% Beta1.83
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin- 52W Low68.92% ATR0.31
Employees50 Current Ratio2.80 Sales Q/Q- Oper. Margin- RSI (14)51.37 Volatility7.67% 8.12%
OptionableYes Debt/Eq0.39 EPS Q/Q-22.30% Profit Margin- Rel Volume0.56 Prev Close3.62
ShortableYes LT Debt/Eq0.32 EarningsMay 08 BMO Payout- Avg Volume356.60K Price3.75
Recom1.70 SMA206.23% SMA503.02% SMA200-14.04% Volume200,543 Change3.59%
May-16-18Initiated Maxim Group Buy $6
May-14-18Reiterated The Benchmark Company Buy $7 → $5
Sep-07-16Reiterated Rodman & Renshaw Buy $12 → $10
Feb-01-16Initiated Rodman & Renshaw Buy $12
Jun-25-20 08:45AM  
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
PR Newswire +6.20%
Jun-10-20 09:34AM  
Cotterford Co. Ltd. Sends Letter to Board of VolitionRX
Business Wire
May-27-20 08:45AM  
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
PR Newswire
May-22-20 04:01PM  
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
PR Newswire
May-20-20 08:45AM  
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
PR Newswire
May-19-20 04:01PM  
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
PR Newswire -9.22%
08:18AM  
VNRX: Q1 2020 Financial and Business Update
Zacks Small Cap Research
May-13-20 05:00PM  
VolitionRx To Present First Data on Nu.Q Capture Performance and Nu.Q Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
PR Newswire
May-07-20 04:10PM  
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
PR Newswire
May-05-20 08:30AM  
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update
PR Newswire
May-04-20 02:43PM  
Is VolitionRx (NYSEMKT:VNRX) Using Too Much Debt?
Simply Wall St.
Apr-29-20 08:30AM  
Volition's Nu.Q Vet Assay Detects Two Common Canine Cancers
PR Newswire
Apr-23-20 08:30AM  
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies
PR Newswire
Mar-28-20 10:53AM  
VolitionRx Limited (NYSEMKT:VNRX) Is Expected To Breakeven
Simply Wall St.
Mar-10-20 08:45AM  
VolitionRx Limited Releases Annual Corporate Brochure and Video
PR Newswire
Mar-03-20 08:30AM  
VolitionRx Limited to Present at Conferences in March 2020
PR Newswire
Feb-18-20 04:10PM  
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
PR Newswire
08:30AM  
Volition Unveils Its Epigenetic Toolbox
PR Newswire
Feb-12-20 01:36PM  
Does The VolitionRx Limited (NYSEMKT:VNRX) Share Price Tend To Follow The Market?
Simply Wall St.
Feb-07-20 05:30PM  
VolitionRx Announces Filing of Registration Statements
PR Newswire -7.46%
Jan-13-20 09:00AM  
Volition Develops a New Improved Nu.Q Assay Format
PR Newswire
Jan-10-20 08:00AM  
VolitionRx Completes Acquisition of Octamer GmbH
PR Newswire
Dec-23-19 02:30PM  
How Many VolitionRx Limited (NYSEMKT:VNRX) Shares Did Insiders Buy, In The Last Year?
Simply Wall St. +5.78%
Dec-16-19 08:30AM  
VolitionRx Limited Announces Strategic Acquisition
PR Newswire
Dec-05-19 08:30AM  
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
PR Newswire -13.36%
Dec-03-19 08:30AM  
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia
PR Newswire
Nov-12-19 04:10PM  
VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
PR Newswire -5.64%
Nov-07-19 08:30AM  
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update
PR Newswire
Oct-29-19 08:30AM  
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
PR Newswire
Oct-25-19 12:00PM  
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
PR Newswire
Oct-18-19 08:30AM  
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
PR Newswire
Oct-09-19 04:05PM  
Volition Appoints Dr. Phillip Barnes to Board of Directors
PR Newswire
Sep-26-19 10:02AM  
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?
Simply Wall St. -8.10%
Sep-17-19 08:35AM  
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
PR Newswire +10.10%
Aug-13-19 06:00AM  
VolitionRX Ltd. to Host Earnings Call
ACCESSWIRE
Aug-12-19 04:05PM  
VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update
PR Newswire
Aug-08-19 08:30AM  
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
PR Newswire
Aug-07-19 08:45AM  
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
PR Newswire
Jul-24-19 04:05PM  
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
PR Newswire +11.11%
Jul-18-19 08:30AM  
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
PR Newswire +5.36%
Jul-10-19 08:30AM  
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
PR Newswire +13.13%
Jun-11-19 10:59AM  
Did You Miss VolitionRx's (NYSEMKT:VNRX) Impressive 116% Share Price Gain?
Simply Wall St.
May-22-19 10:15AM  
VNRX: 2019 Could Be Busy Year of Data Releases, Assay Validations
Zacks Small Cap Research
May-09-19 06:30AM  
VolitionRX Ltd. to Host Earnings Call
ACCESSWIRE
May-08-19 05:37PM  
VolitionRX: 1Q Earnings Snapshot
Associated Press
04:05PM  
VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update
PR Newswire
May-07-19 08:30AM  
VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer
PR Newswire
May-06-19 04:05PM  
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
PR Newswire
Apr-24-19 03:00PM  
VNRX: Entry Into China, Taiwan Large Lung Cancer Study and Animal Diagnostics Subsidiary
Zacks Small Cap Research
Apr-19-19 03:36PM  
Loss-Making VolitionRx Limited (NYSEMKT:VNRX) Expected To Breakeven
Simply Wall St.
Apr-09-19 05:17PM  
VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
PR Newswire
08:30AM  
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
PR Newswire
Apr-03-19 08:30AM  
VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
PR Newswire
Mar-28-19 08:30AM  
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China
PR Newswire
Mar-25-19 08:40AM  
VolitionRx Limited to Present at Conferences in March & April 2019
PR Newswire
Mar-21-19 10:10AM  
VNRX: Initial Product Grade Assay Data is Compelling. Strategy Update On April 9th
Zacks Small Cap Research
Mar-15-19 08:30AM  
VolitionRx Limited to Present at Conferences in the U.S. Next Week
PR Newswire
Mar-13-19 04:05PM  
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
PR Newswire +6.48%
Mar-07-19 08:30AM  
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update
PR Newswire
Feb-15-19 01:38PM  
Have Insiders Been Buying VolitionRx Limited (NYSEMKT:VNRX) Shares?
Simply Wall St.
Nov-14-18 08:50AM  
New Research Coverage Highlights Kandi Technologies Group, AquaVenture, Bridgeline Digital, VolitionRX, USD Partners LP, and ZK International Group Co. Consolidated Revenues, Company Growth, and Expectations for 2018
GlobeNewswire
Nov-07-18 04:05PM  
VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
PR Newswire
Oct-31-18 04:30PM  
VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
PR Newswire -6.12%
Oct-04-18 09:00AM  
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
PR Newswire
Sep-26-18 09:00AM  
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
PR Newswire
Sep-05-18 08:30AM  
VolitionRx Limited to Attend Multiple Conferences in September
PR Newswire
Aug-29-18 09:45AM  
VNRX: More Compelling Prostate Cancer Data, Opportunities Remain for Near-Term Data-Driven Value Inflection
Zacks Small Cap Research
Aug-14-18 06:30AM  
Volitionrx Limited to Host Earnings Call
ACCESSWIRE
Aug-13-18 04:32PM  
VolitionRX: 2Q Earnings Snapshot
Associated Press +13.02%
04:05PM  
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
PR Newswire
08:30AM  
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
PR Newswire
Aug-09-18 08:30AM  
VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
PR Newswire +8.19%
Aug-08-18 06:00AM  
VolitionRx Announces $9 Million Private Placement
PR Newswire
Aug-07-18 08:35AM  
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
PR Newswire
Aug-01-18 07:00AM  
VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today
PR Newswire
Jul-10-18 08:30AM  
Volition Extends Global Reach of its Clinical Trial Program
PR Newswire -5.80%
Jul-02-18 08:30AM  
Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region
PR Newswire +9.00%
Jun-04-18 09:30AM  
SeeThruEquity Issues Update on VolitionRX Ltd. (VNRX) with a Target Price of $7.00
ACCESSWIRE
May-21-18 09:15AM  
VNRX: Triage Data Expected in Coming Weeks, Frontline By Year-End
Zacks Small Cap Research
May-14-18 09:00AM  
VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
PR Newswire
May-10-18 05:04PM  
VolitionRX: 1Q Earnings Snapshot
Associated Press
04:05PM  
VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update
PR Newswire
May-09-18 09:00AM  
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
PR Newswire -7.05%
May-04-18 08:00AM  
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
PR Newswire +9.31%
Mar-21-18 06:22PM  
VolitionRx Limited (NYSEMKT:VNRX): Time For A Financial Health Check
Simply Wall St.
Mar-20-18 09:00AM  
SeeThruEquity Issues Update on VolitionRx (VNRX)
ACCESSWIRE
Mar-15-18 07:50AM  
Wired News OpGen Announces Collaborator in Verification Study for Acuitas® Tests
ACCESSWIRE
Mar-13-18 04:05PM  
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
PR Newswire
Mar-09-18 09:10AM  
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
PR Newswire -22.11%
Mar-08-18 04:01PM  
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
PR Newswire
Mar-07-18 08:30AM  
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
PR Newswire
Mar-06-18 11:00AM  
VNRX: Q4 Results / Operational and Business Update
Zacks Small Cap Research -5.67%
Mar-02-18 05:39AM  
VolitionRx Limited (NYSEMKT:VNRX): Are Analysts Optimistic?
Simply Wall St. +11.43%
Mar-01-18 04:05PM  
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
PR Newswire -8.50%
Feb-28-18 04:05PM  
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
PR Newswire
Feb-26-18 04:05PM  
VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
PR Newswire +6.35%
Feb-05-18 08:30AM  
VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
PR Newswire -7.90%
Jan-03-18 08:30AM  
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone
PR Newswire -5.52%
Dec-05-17 07:30AM  
VolitionRx Limited to Attend Conferences in December
PR Newswire
Nov-22-17 03:00PM  
VNRX: Frontline CRC Studies Read-Out ~1H 2018, Could Be Value-Inflection Event
Zacks Small Cap Research
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRx Limited is headquartered in Austin, Texas.
open in yahoo | open in reuters | open in google